Previous 10 | Next 10 |
2023-05-24 07:14:34 ET Kamada press release ( NASDAQ: KMDA ): Q1 Non-GAAP EPS of $0.04 in-line. Revenue of $30.7M (+9.3% Y/Y) misses by $3.46M . For further details see: Kamada Non-GAAP EPS of $0.04 in-line, revenue of $30.7M misses by $3.46M
2023-05-24 07:13:23 ET Kamada ( NASDAQ: KMDA ) has announced that Chief Financial Officer ( CFO ), Chaime Orlev has withdrawn his resignation and will remain in his position. The company raised $60M through private placement with the FIMI Opportunity Funds, which is expect...
Total Revenues for First Quarter of 2023 were $30.7 Million, Up 9% Year-over-Year First Quarter 2023 EBITDA of $3.8 Million, Increase of 16% Year-over-Year Solid First Quarter Results and Expected Continued Momentum Supported by Multiple Growth Drivers Anticipated to Drive Full-...
2023-05-23 12:43:09 ET Kamada ( NASDAQ: KMDA ) is scheduled to announce Q1 earnings results on Wednesday, May 24th, before market open. The consensus EPS Estimate is $0.04 (+200.0% Y/Y) and the consensus Revenue Estimate is $34.16M (+21.6% Y/Y). Over the last 1 year, K...
REHOVOT, Israel and HOBOKEN, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today ...
Switzerland is the first European country to approve Glassia ® , which received U.S. FDA approval in 2010 Glassia will be commercialized by IDEOGEN AG in Switzerland and the therapy is expected to be available to patients and providers during the second half of 2023 The current A...
Sales of CYTOGAM® Highest Among Four IgG Products Acquired in November 2021 with Approximately $23 Million in Revenues in 2022 , and Gross Margins Over 50% Approval to Manufacture CYTOGAM at Kamada’s Facility to Positively Impact Plant Utilization and Effic...
2023-03-15 16:07:13 ET Kamada Ltd. (KMDA) Q4 2022 Earnings Conference Call March 15, 2023 08:30 AM ET Company Participants Troy Williams - LifeSci Advisors Amir London - CEO Chaime Orlev - CFO Conference Call Participants David Bautz - Zacks Small Cap...
REHOVOT, Israel and HOBOKEN, N.J., March 15, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, ...
Total Revenues for Fiscal Year 2022 of $129.3 Million Represent ed Growth of 25% Compared to Fiscal Year 2021 ; Fourth Quarter 2022 Revenues of $45. 4 Million Represent ed a 44% Increase Year - over - Year Fiscal Year 2022 EBITDA ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 04:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...